Who we are
Founded in 2011, venBio’s venture funds comprise nearly $1.5 billion of committed capital. We are currently investing out of our fourth fund of approximately $550M committed capital. Our team combines scientific, clinical and operating experience in our investment decisions.
How we invest
We take a unique approach to investments, and it has to do with the people in, behind, and associated with our firm. We make all investments as a team; every member of our firm is involved in every investment that we make. We seek the advice of a wide range of expert advisors. Our Limited Partners include both strategic partners (several large biotech and pharma companies) and qualified financial investors. We listen to our LPs and include their expertise in our diligence. We believe we make better decisions this way.
How we work
venBio invests in promising companies at various stages: from early to late stage, and from academic startups to spinouts. We tend to lead most of our investments, and we enjoy building syndicates and teams.
Real
Real
Real
Real
Our strategy
We have always focused on the “Four D’s”, real drugs with real differentiation and real data for real diseases. Our biggest success stories have been companies that have generated strong clinical data for meaningful diseases.
